MA24131A1 - PROCEDE POUR LA PREPARATION DE NOUVEAUX PYRIMIDO (1,2a) INDOLES - Google Patents

PROCEDE POUR LA PREPARATION DE NOUVEAUX PYRIMIDO (1,2a) INDOLES

Info

Publication number
MA24131A1
MA24131A1 MA24544A MA24544A MA24131A1 MA 24131 A1 MA24131 A1 MA 24131A1 MA 24544 A MA24544 A MA 24544A MA 24544 A MA24544 A MA 24544A MA 24131 A1 MA24131 A1 MA 24131A1
Authority
MA
Morocco
Prior art keywords
indoles
preparation
new pyrimido
pyrimido
new
Prior art date
Application number
MA24544A
Other languages
English (en)
Inventor
Lohmer Stefan
Eckenberg Peter
Kolkhof Peter
Grutzmann Rudi
Wohlfeil Stefan
Nielsch Ulrich
Denzer Dirk
Muller Ulrich
Bischoff Hilmar
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MA24131A1 publication Critical patent/MA24131A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA24544A 1996-04-04 1997-04-01 PROCEDE POUR LA PREPARATION DE NOUVEAUX PYRIMIDO (1,2a) INDOLES MA24131A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19613550A DE19613550A1 (de) 1996-04-04 1996-04-04 Neue Pyrimido[1,2-a]indole

Publications (1)

Publication Number Publication Date
MA24131A1 true MA24131A1 (fr) 1997-10-01

Family

ID=7790502

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24544A MA24131A1 (fr) 1996-04-04 1997-04-01 PROCEDE POUR LA PREPARATION DE NOUVEAUX PYRIMIDO (1,2a) INDOLES

Country Status (33)

Country Link
US (1) US6114341A (fr)
EP (1) EP0799828A3 (fr)
JP (1) JPH1059972A (fr)
KR (1) KR970070008A (fr)
CN (2) CN1067393C (fr)
AR (1) AR006497A1 (fr)
AU (1) AU725786B2 (fr)
BG (1) BG62934B1 (fr)
BR (1) BR9701675A (fr)
CA (1) CA2201434A1 (fr)
CO (1) CO4520306A1 (fr)
CZ (1) CZ102297A3 (fr)
DE (1) DE19613550A1 (fr)
DZ (1) DZ2201A1 (fr)
EE (1) EE9700078A (fr)
HN (1) HN1997000045A (fr)
HR (1) HRP970154A2 (fr)
HU (1) HUP9700708A3 (fr)
ID (1) ID16520A (fr)
IL (3) IL120590A (fr)
MA (1) MA24131A1 (fr)
MY (1) MY126362A (fr)
NO (1) NO309092B1 (fr)
NZ (1) NZ314497A (fr)
PE (1) PE42398A1 (fr)
PL (1) PL319249A1 (fr)
SG (1) SG63698A1 (fr)
SK (1) SK42797A3 (fr)
SV (1) SV1997000025A (fr)
TN (1) TNSN97061A1 (fr)
TR (1) TR199700261A2 (fr)
YU (1) YU12397A (fr)
ZA (1) ZA972829B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826469A1 (de) * 1998-06-13 2000-05-25 Bayer Ag Verfahren zur Herstellung von 2,4-Dimethylcarbolin und 2,4-Dimethylpyrimido[1,2-a]indol
WO2001074817A1 (fr) * 2000-03-30 2001-10-11 Yamanouchi Pharmaceutical Co., Ltd. Derives d'hydrazide
DE10030375A1 (de) * 2000-06-21 2002-01-03 Bayer Ag Verwendung von MTP-Inhibitoren zur Senkung von ppTRL
JP4254093B2 (ja) * 2001-10-17 2009-04-15 宇部興産株式会社 5−ハロゲノインドールの製法
DE10349175A1 (de) * 2003-10-22 2005-05-19 Bayer Healthcare Ag Mittel zur Gewichtsreduktion
CA2910191C (fr) 2004-03-05 2022-03-08 The Trustees Of The Univeristy Of Pennsylvania L'utilisation d'inhibiteurs mtp pour le traitement a faibles effets secondaires contre des affections liees a l'hyperlipidemie et l'hypercholesterolemie
US20080280922A1 (en) * 2004-04-09 2008-11-13 Marc Alois Celine Maria Engelen Intermittent Dosing Regimen For Overweight and Obese Subjects
CA3029306C (fr) 2005-05-12 2020-12-29 C.R. Bard Inc. Filtre amovible pour caillot sanguin ou embole
EP1890767A2 (fr) * 2005-05-27 2008-02-27 Pfizer Products Inc. Combinaison d'un antagoniste des recepteurs cannabinoides-1 et d'un inhibiteur des proteines microsomales de transfert de triglycerides pour traiter l'obesite ou maintenir une perte de poids
WO2007021340A1 (fr) 2005-08-09 2007-02-22 C.R. Bard Inc Filtre pour caillots de sang generateurs d'embolie et systeme de mise en place
CA2626441A1 (fr) * 2005-10-18 2007-04-26 Aegerion Pharmaceuticals Methodes permettant de traiter les troubles associes a l'hyperlipidemie chez un mammifere
US10188496B2 (en) 2006-05-02 2019-01-29 C. R. Bard, Inc. Vena cava filter formed from a sheet
US20080161279A1 (en) * 2006-12-21 2008-07-03 Wisler Gerald L Methods of Treating Obesity
CA3186856A1 (fr) 2020-07-29 2022-02-03 Ruth NALLEN Lomitapide destine a etre utilise dans des methodes de traitement de l'hyperlipidemie et de l'hypercholesterolemie chez des patients pediatriques

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA718536B (en) * 1971-01-11 1972-09-27 Wyeth John & Brother Ltd Heterocyclic compounds
DE2200584A1 (de) * 1971-01-11 1972-07-27 Wyeth John & Brother Ltd Heterocyclische Verbindungen,Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
GB8614246D0 (en) * 1986-06-11 1986-07-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate
DE4309968A1 (de) * 1993-03-26 1994-09-29 Bayer Ag Phenylglycinamide von heterocyclisch substituierten Phenylessigsäurederivaten
DE4208052A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Imidazolyl substituierte phenylessigsaeureamide
DE4208051A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Substituierte phenylessigsaeureamide
US5576342A (en) * 1992-03-13 1996-11-19 Bayer Aktiengesellschaft Phenylglycinamides of heterocyclically substitued phenylacetic acid derivatives
WO1994010174A1 (fr) * 1992-11-05 1994-05-11 Smithkline Beecham Plc Derives de piperidine utiles comme antagonistes de recepteur de 5-ht4
DE4302956A1 (de) * 1993-02-03 1994-08-04 Bayer Ag Substituierte Imidazo(4,5-b)pyridine und Benzimidazole

Also Published As

Publication number Publication date
YU12397A (en) 1999-11-22
NO309092B1 (no) 2000-12-11
HUP9700708A3 (en) 2000-01-28
TNSN97061A1 (fr) 2005-03-15
EP0799828A2 (fr) 1997-10-08
US6114341A (en) 2000-09-05
SK42797A3 (en) 1997-11-05
BG101379A (en) 1997-11-28
BG62934B1 (bg) 2000-11-30
HRP970154A2 (en) 1998-04-30
ID16520A (id) 1997-10-09
HU9700708D0 (en) 1997-05-28
KR970070008A (ko) 1997-11-07
AR006497A1 (es) 1999-08-25
CN1176965A (zh) 1998-03-25
PL319249A1 (en) 1997-10-13
MY126362A (en) 2006-09-29
EE9700078A (et) 1997-10-15
CA2201434A1 (fr) 1997-10-04
CN1067393C (zh) 2001-06-20
NO971512D0 (no) 1997-04-03
SV1997000025A (es) 1997-10-23
JPH1059972A (ja) 1998-03-03
CZ102297A3 (en) 1997-10-15
NO971512L (no) 1997-10-06
EP0799828A3 (fr) 1998-04-08
CO4520306A1 (es) 1997-10-15
HN1997000045A (es) 1997-06-26
HUP9700708A2 (hu) 1998-10-28
IL131645A (en) 2000-12-06
MX9702445A (es) 1997-10-31
DE19613550A1 (de) 1997-10-09
IL120590A0 (en) 1997-08-14
TR199700261A2 (xx) 1997-10-21
PE42398A1 (es) 1998-10-12
NZ314497A (en) 1999-10-28
IL131645A0 (en) 2001-01-28
IL120590A (en) 2000-02-17
SG63698A1 (en) 1999-03-30
CN1312246A (zh) 2001-09-12
DZ2201A1 (fr) 2002-12-03
AU725786B2 (en) 2000-10-19
AU1660397A (en) 1997-10-09
BR9701675A (pt) 1998-11-03
ZA972829B (en) 1997-10-31

Similar Documents

Publication Publication Date Title
MA24426A1 (fr) Procede pour la preparation de nouveaux composes
MA24205A1 (fr) Procede pour la preparation du sildenafil
MA23270A1 (fr) Procede pour la preparation de nouveaux composes.
MA23792A1 (fr) Procede pour la preparation de nouveaux composes
MA24011A1 (fr) Procede pour la preparation de nouveaux composes
MA23802A1 (fr) Procede pour la preparation de nouveaux composes
MA22922A1 (fr) Procede pour la preparation de nouveaux composes .
MA24055A1 (fr) Procede pour la preparation de nouveaux imidazoles cycloalkyles substitues
FR2740132B1 (fr) Procede pour la preparation de 1,1,1,3,3-pentafluoropropane
MA24427A1 (fr) Procede pour la preparation de nouveaux composes
MA22923A1 (fr) Procede de preparation de nouveaux composes .
MA25223A1 (fr) Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine
MA21645A1 (fr) Procede pour la preparation de nouveaux derives d'rtemisinine.
MA24182A1 (fr) Procede pour la preparation de 2,4-diaminopyrimidines substituees
MA22955A1 (fr) Procede pour la preparation de nouveaux composes .
MA24131A1 (fr) PROCEDE POUR LA PREPARATION DE NOUVEAUX PYRIMIDO (1,2a) INDOLES
MA24246A1 (fr) Procede de preparation de frites dorees au four ameliorees
MA22860A1 (fr) Procede pour la preparation de nouveaux composes.
MA24355A1 (fr) Procede de preparation de nouveaux composes
MA23309A1 (fr) Procede de preparation de nouveaux composes.
FR2781801B1 (fr) Procede pour la preparation de dianhydride pyromellique
EP1023250A4 (fr) Procede de preparation de 2,6-dialkylnaphtalene
MA24142A1 (fr) Procede pour la preparation de nouveaux retinoides .
FR2733227B1 (fr) Procede pour la preparation de 1,1-difluoroethane
MA24245A1 (fr) Procede pour la preparation de nouveaux composes sulfonylures